Ashiya, Japan

Koichiro Jitsukawa


Average Co-Inventor Count = 7.3

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Otsu, JP (1989)
  • Ashiya, JP (1990 - 1993)
  • Hyogo, JP (1993)

Company Filing History:


Years Active: 1989-1993

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Profile of Inventor Koichiro Jitsukawa**

Introduction

Koichiro Jitsukawa, an innovative inventor based in Ashiya, Japan, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of six patents, he has focused on developing antimicrobial compounds that hold great potential for medical applications.

Latest Patents

Among his recent patents, two notable inventions stand out. The first is centered around isocephem derivatives, specifically a cephalosporin derivative represented by a series of complex formulae, which are designed as potential active ingredients in antimicrobial agents. The second patent involves pyrroloquinoline derivatives, which also showcase antimicrobial activity and are structured with specific chemical components to enhance their efficacy.

Career Highlights

Jitsukawa currently works for Otsuka Pharmaceutical Company, Limited, where he applies his expertise in drug development to create new therapeutic solutions. His work has the potential to impact the pharmaceutical industry positively, particularly in the realm of antibiotics and other antimicrobial agents.

Collaborations

Throughout his career, Jitsukawa has collaborated with noted colleagues such as Hiroshi Ishikawa and Hidetsugu Tsubouchi. These collaborations have contributed to the advancement of his research and the successful development of his patented innovations.

Conclusion

Koichiro Jitsukawa exemplifies the role of modern inventors in addressing complex health challenges through innovation. His dedication to producing effective antimicrobial solutions illustrates the profound impact that focused research and collaboration can have in the pharmaceutical field, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…